Clin2
NCT07363122Possibly a fitNot yet recruiting

Platelet changes in type 2 diabetes

Platelet IndicesType 2 DiabetesInflammatory Markers

Part of Hormones & metabolism clinical trials.

This study looks at how platelets (the cells that help your blood clot) change in people with type 2 diabetes. It may help doctors understand diabetes better and find new ways to manage it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
30 years to 70 years
Study type
Observational

Who can take part

  • You are between 30 and 70 years old.
  • You have had type 2 diabetes for at least 1 year.
  • Your fasting blood sugar is 126 mg/dL or higher, or your HbA1c (average blood sugar over 2-3 months) is 6.5% or higher.
  • You are not taking any anti-platelet or anti-inflammatory medications (like aspirin or ibuprofen).
  • You do not have any infection, chronic inflammatory disease, cancer, or serious liver, kidney, or blood disorders.
  • You have not had major surgery or a serious injury in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07650682Recruiting
Blood Sugar and Hormone Patterns in Type 2 Diabetes

This study uses math models to understand how your blood sugar and hormones respond to food and insulin. You'll eat study foods and provide blood samples so researchers can better predict how your body handles diabetes.

Chicago, Illinois
NCT05501483Recruiting
Study how fat differences may relate to type 2 diabetes

This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.

Stockholm
NCT05702463Recruiting· Phase 1
Daily aspirin in adults with type 2 diabetes

This early-stage study tests how a daily aspirin tablet behaves in the body and how it affects blood/clotting markers in people with type 2 diabetes. It may help researchers understand whether this form of aspirin could be useful, especially if you’re not currently taking aspirin.

Montreal, Quebec
NCT05593549Recruiting· Early Phase 1
Studying blood vessel damage in type 2 diabetes

This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.

Milwaukee, Wisconsin
NCT06108388Not yet recruiting
Study of blood vessel health in type 2 diabetes

This study looks at how well the cells lining your blood vessels work and how the body's regenerative cells may behave in people with or without type 2 diabetes. It involves giving a blood sample and answering questions to help researchers understand blood vessel health.

Scarborough Village, Ontario
NCT07556497Recruiting
Blood cells and inflammation in diabetic heart disease

This study looks at why people with type 2 diabetes develop heart problems. Researchers will examine special cells in your blood and inflammation markers to better understand these complications.

Doha

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.